$ACN

Unruch Joel sold $1.7M of ACN

Unruch Joel (General Counsel/Corp Secretary) sold 10,498 shares of Accenture plc (ACN) at an average of $162.98 ($160.86–$165.16, $1.71M total) across 5 trades on 2026-07-30 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Unruch Joel
Published Jul 31, 2026, 8:04 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 8:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ACN
Neutral
medium confidence
Mentioned
$ACN
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACNNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale size, price range, and post-transaction holdings by the company’s General Counsel/Corp Secretary under a 10b5-1 plan.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 pre-arrangement reduces the likelihood of a fundamental signal.

03

What to watch

Because the sale is explicitly under a 10b5-1 plan, the informational content is usually lower than discretionary selling; also, the article does not state any change in business outlook.

Relevance 5/10Novelty 3/10Timing: filed 2026-07-31 after 2026-07-30 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Accenture plc (ACN).

Company-level read

Ticker impact

$ACNNeutralMedium confidence
Context

Accenture insider Form 4 shows General Counsel Joel Unruch sold 10,498 shares on 2026-07-30 under a 10b5-1 plan for about $1.71M.

Expected impact

Limited, likely no sustained price impact unless accompanied by other disclosures.

Evidence & confidence

The filing is a scheduled open-market sale by an officer under a pre-arranged 10b5-1 plan; the article provides no new operational, financial, or regulatory catalyst.

Market effects

No clear sector read-through; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Insider sales can still reflect private liquidity needs or tax planning, but if repeated at elevated frequency it can be interpreted as caution by some traders.

Key entities

  • Accenture plc

    Subject of the Form 4 insider transaction disclosure.

  • Unruch Joel

    General Counsel/Corp Secretary who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACNMed

Consulting sector outlook: Accenture leads on AI monetization and ROIC

Consulting sector sentiment is cautiously optimistic, with Accenture (ACN) highlighted for its AI monetization and 60.1% fair-value upside. UBS reiterated a Buy rating on ACN with a $275 target. ACN's revenue grew 38% from 2021 to 2025, with a 22.9% ROIC and 13.7x forward P/E. Genpact (G) and FTI Consulting (FCN) are also mentioned, with lower valuations but different risks.

HighAI 9/10

TCS Emerges Ahead Of Accenture To Take Over Best Buy's India GCC Operations

TCS won a 5-year, Rs 2,000 crore deal to manage Best Buy's India GCC operations, beating Accenture. The Bengaluru center has 600 employees and covers data, analytics, and AI services. TCS offered competitive pricing and productivity improvements. The deal expands TCS's existing relationship with Best Buy, which generates $75-100 million annually in revenue, according to HFS Research.

$ACNMed

Q2 Earnings Recap: Gartner (NYSE:IT) Tops IT Services & Consulting Stocks

Accenture (NYSE:ACN) reported Q2 revenue of $18.72B, up 5.6% YoY, in line with expectations but missed guidance. IBM (NYSE:IBM) reported $17.16B, up 1.1% YoY, missing estimates by 1.5%. Kyndryl (NYSE:KD) reported $3.62B, down 3.3% YoY, missing revenue expectations but beating EPS estimates. ACN and IBM stocks are up 13.3% and 13.6% since reporting, while KD is down 8.5%.

$ACNMedAI 8/10

Accenture and AWS step up Middle East push into cloud and AI

Accenture and Amazon Web Services (AWS) signed a six-year deal to support Middle East businesses and governments in adopting cloud and AI technologies. The agreement focuses on modernizing legacy systems, migrating workloads, and deploying AI across sectors like energy and financial services. Gulf nations are investing heavily in AI infrastructure, with projects like the UAE's $30B UAE-US AI Campus and Saudi Arabia's 467MW data center capacity. AWS is also expanding in Saudi Arabia, with a new c

$ACNLow

ADHA sticks with Accenture for My Health Record support

The Australian Digital Health Agency (ADHA) awarded Accenture a $161.6M contract for My Health Record infrastructure services, running from 2026 to 2029 with an extension option. The deal covers the My Health Record system and ADHA's API gateway. ADHA CEO Amanda Cattermole noted over 25M active records and 207M clinician uses in the past year. Telstra Health secured a separate $33.2M contract for FHIR-based data architecture.

$KDLow

Q2 Rundown: Kyndryl (NYSE:KD) Vs Other IT Services & Consulting Stocks

Kyndryl (KD) reported Q2 revenue of $3.62B, down 3.3% YoY, missing estimates by 0.7% but beating EPS. Gartner (IT) reported $1.68B revenue, up 1.8% YoY, beating estimates. Accenture (ACN) reported $18.72B revenue, up 5.6% YoY, in line with estimates but missed guidance. IBM (IBM) reported $17.16B revenue, up 1.1% YoY, missing estimates by 1.5%. DXC (DXC) reported $3.00B revenue, down 5.1% YoY, in line with estimates but missed EPS.